Memantine

Therapies for Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive, fatal disorder without cure. The mechanism(s) of the disease is not entirely understood, impeding development of effective therapy. Current treatments provide short-term alleviation of some symptoms, but generally […]

Alzheimer’s Disease-Market Analysis of Prescription Drugs

The World Health Organization (WHO) reported on December 12, 2017 that there are approximately 50 million people with dementia worldwide, of which nearly 60% are living in low- and middle-income […]

Progress in The Development of New Drugs in Alzheimer’s Disease

Progress in The Development of New Drugs in Alzheimer’s Disease

Alzheimer’s disease (AD) is an age-related neurodegenerative disease that is characterized by a progressive loss of memory associated with other cognitive sphere deficits interfering with social and occupational functioning. The […]